Abstracts Archive - Page 510 of 1683 - ATC Abstracts

2020 American Transplant Congress
Percutaneous Choledochoscopy and Laser Biliary Stricturoplasty: A Case Series of Novel Management of Refractory Post-Liver Transplant Biliary Complications
W. E. Jackson¹, P. S. Trivedi², J. J. Pomposelli³, T. J. Pshak³
¹Division of Gastroenterology and Hepatology, University of Colorado, Aurora, CO, ²Division of Vascular and Interventional Radiology, University of Colorado, Aurora, CO, ³Division of Transplant Surgery, University of Colorado, Aurora, CO
*Purpose: Anastomotic biliary strictures are a well-recognized complication after living and deceased donor liver transplant (LDLT and DDLT). Management focuses on utilizing endoscopic retrograde cholangiography…
2020 American Transplant Congress
Defining the Psychological Profile of Living Organ Donors Using Personality Assessment Inventory
W. T. Branagan¹, S. Huett¹, M. Grafals², W. E. Jackson³, E. A. Pomfret⁴
¹Division of Psychiatry, University of Colorado, Aurora, CO, ²Division of Renal Diseases and Hypertension, University of Colorado, Aurora, CO, ³Division of Gastroenterology and Hepatology, University of Colorado, Aurora, CO, ⁴Division of Transplant Surgery, University of Colorado, Aurora, CO
*Purpose: We aim to assess the psychological profile of living organ donors using normative referenced psychological assessment of personality and pathology.*Methods: Evaluation for living kidney…
2020 American Transplant Congress
Rapid Preparation to Undergo ABO-Incompatible Living Donor Liver Transplantation for Acute Liver Failure
H. Hung¹, C. Lee², Y. Wang¹, J. Lee², C. Cheng¹, T. Wu¹, T. Wu¹, H. Chou¹, K. Chan¹, W. Lee²
¹Chang-gung Hospital, Taoyuan, Taiwan, ²Chang-gung Hospital, Taiyuan, Taiwan
*Purpose: Acute liver failure is a life-threatening condition and urgent liver transplantation is needed to save lives. In the circumstance of deceased and ABO-compatible (ABO-C)…
2020 American Transplant Congress
Anonymous Living Donor Liver Donation: Establishing A Protocol and Understanding Donors Experience
S. Shan¹, J. Durden¹, T. Seay², P. Vargas³, S. Pelletier³, J. Oberholzer³, C. Argo⁴, N. Goldaracena³
¹School of Medicine, University of Virginia Health System, Charlottesville, VA, ²Division of Transplantation, University of Virginia Health System, Charlottesville, VA, ³Department of Surgery, Division of Transplantation, University of Virginia Health System, Charlottesville, VA, ⁴Department of Medicine-Gastroenterology, University of Virginia Health System, Charlottesville, VA
*Purpose: Anonymous living liver donation (ALLDs) are not as widely accepted as directed donations from friends and family, despite having significant potential to help mitigate…
2020 American Transplant Congress
Atrial Fibrillation Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort
M. German¹, A. Hristov¹, A. Lee¹, F. Osman¹, A. Kwong², D. Devuni³, C. Wang⁴, J. Boike⁵, J. Jo⁵, L. VanWagner⁵, M. Serper⁶, R. Sharma⁷, E. Verna⁷, J. Shor³, A. Koteish⁸, G. Sehmbey⁹, A. Seetharam⁹, N. John², Y. Patel¹⁰, M. Kappus¹⁰, T. Couri¹¹, S. Paul¹¹, R. Salgia¹², Q. Nhu¹³, C. Frenette¹³, J. Lai⁴, A. Goel², E. Spengler¹
¹U of Wisconsin, Madison, WI, ²Stanford, Palo Alto, CA, ³U of Massachusetts, Worcester, MA, ⁴U of California, San Francisco, CA, ⁵Northwestern, Chicago, IL, ⁶U of Pennsylvania, Philadelphia, PA, ⁷Columbia, New York, NY, ⁸Florida Hospital, Orlando, FL, ⁹U of Arizona, Phoenix, AZ, ¹⁰Duke, Durham, NC, ¹¹U of Chicago, Chicago, IL, ¹²Henry Ford Hospital, Detroit, MI, ¹³Scripps, San Diego, CA
*Purpose: More liver transplants (LT) are being performed in patients >65 years (y) - a population with higher rates of cardiovascular (CV) disease. It is…
2020 American Transplant Congress
Impact of Pre-Liver Transplant Cardiovascular Disease Risk Assessment Standardization on Resource Utilization and Recipient Selection
J. Rice¹, D. Hughes¹, J. R. Burton¹, E. D. Pomfret², J. J. Pomposelli², A. V. Ambardekar³, M. Kriss¹
¹Division of Gastroenterology and Hepatology, University of Colorado School of Medicine, Aurora, CO, ²Division of Transplant Surgery, University of Colorado School of Medicine, Aurora, CO, ³Division of Cardiology, University of Colorado School of Medicine, Aurora, CO
*Purpose: Cardiovascular disease (CVD) risk assessment (RA) prior to liver transplantation (LT) is a critical aspect of recipient selection, however data on optimal testing is…
2020 American Transplant Congress
The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is it Time to Split the Difference?
D. Yoeli¹, M. Adams¹, R. Choudhury¹, T. Nydam¹, J. Pomposelli¹, J. Goss², M. Wachs¹
¹Transplant Surgery, University of Colorado, Aurora, CO, ²Transplant Surgery, Baylor College of Medicine, Houston, TX
*Purpose: The opioid epidemic afflicting our nation has led to a surge in the number of adult deceased donors from drug overdose. We hypothesized that…
2020 American Transplant Congress
Multifactorial Effect of Hepatocyte Growth Factor (HGF) on the Microscopic Regeneration of Liver Allograft in Recipients Who Underwent Transplantation from Living Donors
B. H. Ozdemir¹, G. Ozgun¹, A. Yucel Polat¹, M. Haberal²
¹Pathology, Baskent University, Ankara, Turkey, ²Department of General Surgery, Division of Transplantation, Baskent University, Ankara, Turkey
*Purpose: Although partial liver allografts from living donors have near-complete regeneration of their liver volumes within weeks after transplantation, the microscopic range of regeneration is…
2020 American Transplant Congress
Management of Hepatic Artery Stenosis Post Liver Transplant
S. Bommena, I. Joshi, P. Kang, T. Chaly, A. Seetharam, N. Patel, M. B. Fallon, S. Mehta
Banner University Medical Center, University of Arizona College of Medicine, Phoenix, AZ
*Purpose: Hepatic Artery Stenosis (HAS) is a significant complication after liver transplantation associated with morbidity. The primary aim of this study is to determine if…
2020 American Transplant Congress
Clinical Study of Standard versus Reduced Dose Tacrolimus Combined with Generic Mycophenolate Mofetil in De Novo Kidney Transplantation
J. Bang, C. Oh
Department of Surgery, Ajou University Medical School, Suwon, Korea, Republic of
*Purpose: The lowering of calcineurin inhibitor exposure is possibly considered as the proper strategy to prevent calcineurin inhibitor induced nephrotoxicity in kidney transplant. This clinical…